Since they appeared in resistant diseases and evolved in parallel, mutations in the KDM/KMT gene family are promising candidates as relapse drivers in MM, further supporting the role of epigenetic modifiers in the evolution of high-risk disease23. The gene discussed is CAMKMT; the disease is Miyoshi myopathy.